France· FR:61814540
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL SANDOZ 600 mg/200 mg/245 mg, comprimé pelliculé
A medicinal product containing éfavirenz + succinate de ténofovir disoproxil + emtricitabine, registered in France by SANDOZ, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉFAVIRENZ + SUCCINATE DE TÉNOFOVIR DISOPROXIL + EMTRICITABINE
- Manufacturer
- SANDOZ
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930117576flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)EUR 225.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Éfavirenz + succinate de ténofovir disoproxil + emtricitabine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAtriplaAbacus Medicine A/S
- GermanyEfavemtenTad Pharma Gmbh
- CzechiaEFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL KRKAKrka, d.d., Novo mesto, Novo mesto
- United Statesefavirenz, emtricitabine and tenofovir disoproxil fumarateCipla USA Inc.
- United KingdomAtripla 600mg/200mg/245mg tabletsGilead Sciences Ltd
- CanadaAPO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRAPOTEX INC
- SwedenEfavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/200 mg/245 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
- IrelandEfavirenz/Emtricitabine/Tenofovir disoproxil Krka 600 mg/200 mg/245 mg film-coated tabletsKRKA, d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
- Germany · Efavemten, Efavirenz/Emtricitabin/Tenofovirdisoproxil Aliud
- Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
- Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
- Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
- Finland · Fatrino
- United Kingdom (Northern Ireland) · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark Pharmaceuticals Europe, Efavirenz/Emtricitabine/Tenofovir Disoproxil Macleods
- Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
- Ireland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
- Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
- Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
- Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
- Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
- Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
- Poland · Efavirenz + Emtricitabine + Tenofovir Disoproxil Aurovitas
- Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
- Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
- Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1e70812-dc33-4e74-82f6-d8b4fda5368f GET /v1/drugs/f1e70812-dc33-4e74-82f6-d8b4fda5368f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61814540",
"date_amm": "2017-11-16",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "ÉFAVIRENZ + SUCCINATE DE TÉNOFOVIR DISOPROXIL + EMTRICITABINE",
"statut_amm": "Autorisation suspendue",
"statut_bdm": "Alerte",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about éfavirenz + succinate de ténofovir disoproxil + emtricitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.